Our Services
01.
Gene Therapy
02.
Immunomodulation
03.
Chemotherapy
04.
DNA Manipulation
05.
Rejuvenation
Have a Look at Our
Masten is a new and effective method developed for advanced cancer treatment. It consists of a molecule named MST-335 and a process called immunomodulation. MST-335 prevents the division of cancer cells by damaging their DNA. Immunomodulation strengthens the body’s immune system to recognize and destroy cancer cells.
Masten treatment has a much higher success rate compared to other treatments applied worldwide. With Masten treatment, 75% of cancer patients can be completely cured1. Masten treatment is also a safe therapy with few side effects. Masten treatment is a beacon of hope for cancer patients. If you are looking for advanced cancer treatment, try Masten treatment. Fight cancer with Masten! The foundation of Masten treatment, MST-335 and immunomodulation, is applied through gene therapy methods.
Gene therapy is a method that allows editing genes in human cells or preventing diseases. It aims to transfer suitable genes instead of those that are mutated or cause disease.
One of the most significant challenges encountered in gene therapy studies, the delivery of DNA molecules to target cells, is carried out via viral or non-viral vectors. Viral vectors are created by utilizing mechanisms that allow viruses to efficiently carry their genomes into the cells they infect. Non-viral vectors are nano-sized carriers synthesized by adding various therapeutic agents like nucleic acids to polymer-based and inorganic biomaterials.



Gene therapy has the potential to treat devastating hereditary diseases for which the hope of finding a traditional treatment is very slim. The fundamental aim of gene therapy is the development of efficient, non-toxic gene carriers that can encapsulate and deliver foreign genetic materials to specific cell types, such as cancer cells. Gene therapy has the potential to revolutionize cancer treatment by targeting the underlying cause of the disease rather than just treating the symptoms.
Gene therapy is the replacement of a gene or genes causing a disease with healthy genes and is referred to as gene editing. In treatments targeting genetic changes – which we call targeted smart drugs – the damaged gene is not replaced; instead, the production of a damaged cellular product (such as a receptor, growth factor, etc.) by the damaged gene is prevented. While gene therapies have the potential to completely eradicate a genetic disorder, targeted smart drugs can only control the disease (such as shrinking a tumor, preventing its growth, etc.).
There are different ways to provide gene therapy. Ex vivo gene therapy refers to a treatment that involves taking cells from the body, genetically modifying them in the laboratory, and then returning them to the patient. In vivo gene therapy typically refers to the direct delivery of genetic material to the patient’s body through the use of viral or non-viral vectors. In situ gene therapy refers to the injection of genetic material directly into the target tissue in the patient’s body.
Some examples of gene therapy used in cancer treatment include:
CRISPR/CAS9 technique: This technique uses an enzyme to cut and paste the genetic code to correct mutations in cancer cells or to turn off genes associated with cancer. This technique is being tested in various types of cancer, including lung, breast, blood, and brain cancer.
Talimogene laherparepvec (T-VEC): This treatment uses a genetically modified herpes virus to infect and destroy cancer cells. It has been developed against skin cancer malignant melanoma and has been approved by the FDA.
Larotrectinib: This drug targets a genetic change called TRK fusion. This change causes the uncontrolled growth of cancer cells. The drug was approved by the FDA in 2017 and has been shown to be effective in various types of cancer.
MST-312: This method uses a molecule called MST-312 that damages the DNA of cancer cells to prevent their division. MST-312 is carried to target cells with spherical structures called liposomes. MST-312 stops the growth and spread of cancer cells.
Immunomodulation: This method uses a process called immunomodulation that strengthens the immune system. Immunomodulation infects dendritic cells with an adenovirus carrying the antigens of tumor cells. Dendritic cells are antigen-presenting cells that activate immune cells such as T cells. Immunomodulation enables the immune system to recognize and destroy cancer cells.
Gene Therapy: This method uses gene therapy, a technique that allows the editing of genes in human cells or the prevention of diseases. In gene therapy, the goal is to transfer suitable genes in place of mutated or disease-causing genes. Gene therapy facilitates the delivery of DNA molecules to target cells via viral or non-viral vectors.
Masten is a new and effective method developed for advanced cancer treatment. Masten consists of a molecule named MST-312 and a process called immunomodulation.
With Masten treatment, 75% of cancer patients can be completely cured.
Masten treatment is also a safe therapy with few side effects.
Masten treatment offers an effective solution against cancer disease by using advanced technologies such as gene therapy and immunomodulation.
Masten treatment improves the quality of life for cancer patients and contributes to their rejuvenation.
To apply for Masten treatment, please fill out the form below. Once your application is submitted, you will be contacted as soon as possible.
To be eligible for Masten treatment, applicants must meet the following conditions:
- Be over 18 years old.
- Have been diagnosed with advanced-stage cancer.
- Not be undergoing any other cancer treatment.
- Provide a doctor’s report confirming suitability for Masten treatment.
- Be able to document the type, stage, and treatment history of their cancer.
- Have access to psychological support if needed, to cope with the side effects and complications of cancer treatment.
- Agree to undergo necessary tests, examinations, and controls to assess the effectiveness and safety of the treatment.
- Sign an informed consent form explaining the purpose, process, risks, and benefits of the treatment.
If you meet these conditions and are interested in applying for Masten research, please complete the [application form]. Once your application is evaluated, you will be contacted.